The novel therapy of this peptide represents a major breakthrough in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide172334.blogdun.com/42732436/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment